GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

Obesity is a significant risk factor for various metabolic diseases and, in many cases, causes ectopic fat accumulation (i.e.

Propranolol and metoprolol are beta-blockers taking to treat certain heart conditions. Learn more about their similarities ...

Adults with type 1 diabetes who initiated treatment with a bionic pancreas at a primary care site experienced similar glycemic benefits as those starting the device through an endocrinologist, ...

The following is a summary of “Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital Discharge,” published in the March ...

A review published in Nutrients finds that ketogenic diets (KD) may offer superior benefits for weight loss, blood sugar ...

GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin ...

The following is a summary of “Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: Insights from the CREDENCE trial,” published in the February 2025 issue of Nephrology Dialysis ...

A new study from Northwestern University has found that two widely prescribed type 2 diabetes medications—sulfonylureas and ...

Learn more about whether GE HealthCare Technologies Inc. or Insulet Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...

Insulin resistance correlates with disease severity in CTEPH, and an indicator may help predict clinical worsening in ...